An Oklahoma clinical trial is testing a drug designed to slow the progression of Parkinson’s disease, not just treat symptoms, and researchers say there are still spots open for eligible patients to join.
Doctors call the study one of the most promising they’ve seen in years, and one Oklahoma woman says it may already be helping her.
Read more about the trial, who qualifies and how to learn about enrolling:
–
–
